Yanli Xu

513 citations
38 papers · 325 indexed · h-index 12
Topics
Acute Myeloid Leukemia Research (6 papers)Multiple Myeloma Research and Treatments (4 papers)Blood properties and coagulation (3 papers)

In The Last Decade

Yanli Xu

30 papers receiving 319 citations

Peers

Yanli Xu
Comparison fields: 5 of 84
  • Hematology 94
  • Molecular Biology 83
  • Oncology 65
  • Surgery 46
  • Immunology 45
Replace Elisa Dorantes‐Acosta with:
Elisa Dorantes‐Acosta Mexico
Donata Urbaniak‐Kujda Poland
Chantal Farra Lebanon
Ludovic Suner France
Jesper Haaning Denmark
Muss Hb United States
Ami Patel United States
Bérengère de Laval France
Kenneth Washenik United States
Gabriel Brisou France
Yanli Xu relative to Elisa Dorantes‐Acosta Mexico Elisa Dorantes‐Acosta's profile →
Citations per field
00.5×4.6×
Elisa Dorantes‐Acosta · 1×
Citations per year

Countries citing papers authored by Yanli Xu

Since Specialization
Citations

This map shows the geographic impact of Yanli Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanli Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanli Xu more than expected).

Fields of papers citing papers by Yanli Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanli Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanli Xu. The network helps show where Yanli Xu may publish in the future.

Co-authorship network of co-authors of Yanli Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanli Xu. A scholar is included among the top collaborators of Yanli Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanli Xu. Yanli Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 0
5 3
6 3
7 4
8 2
9 4
10 6
11 26
12 2
13 3
14 11
15 38
16 5
17 23
18
[Effects of radix Astragali injection on apoptosis of lymphocytes and immune function in patients with systemic lupus erythematosus].
11
19 24
20 7

About Yanli Xu

Yanli Xu is a scholar working on Hematology, Pharmacy and Genetics, having authored 38 papers that have together received 325 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (6 papers), Multiple Myeloma Research and Treatments (4 papers) and Blood properties and coagulation (3 papers). The work is most often cited by research in Hematology (94 citations), Genetics (40 citations) and Obstetrics and Gynecology (27 citations). Yanli Xu has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Xuezhong Zhang, Xiuqun Zhang, Dan Yang, Ping Mao, Wei Yi, Xiaohong Chen, Yuping Zhang, Ailing Su, Xin‐En Huang and Shunqing Wang. Their work appears in journals such as SHILAP Revista de lepidopterología, The Journal of Infectious Diseases and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026